The short answer
Yes, you can advertise supplements on Facebook, Instagram and Google. Neither platform bans the category. What both ban are specific ingredients, specific claims and specific ways of presenting results, and both review the ad, the targeting and the page it sends people to.
The advice you find in forum threads tends to be about getting ads past review: altered spellings, swapped landing pages, fresh accounts after a ban. Those tactics are named violations in both platforms' policies, and they put the whole business at risk, not one ad. This guide covers the opposite approach: what is allowed, how to write claims that hold up, and how to build an account that survives the next policy change.
Rules differ by country and change often. Nothing here is legal advice. Take regulatory advice on your own products and claims before you spend.
Platform policy decides whether the ad runs. Advertising law decides whether the claim is lawful. An ad can pass Meta or Google review and still make a claim the FTC would treat as deceptive.
What Google and Meta allow
Google covers supplements under its Healthcare and medicines policy. The Unapproved substances section says Google does not allow the promotion of certain products "regardless of any claims of legality". That includes products containing ephedra, products containing hCG in relation to weight loss, herbal and dietary supplements with active pharmaceutical or dangerous ingredients, products that imply they are as effective as prescription drugs, products not approved by a government body that are marketed as safe or effective for a particular disease, and products that have been subject to government or regulatory action or warning.
Google also publishes a list of unapproved pharmaceuticals and supplements. It is explicitly not exhaustive: it gives examples of the product types it monitors, including named weight loss and sexual performance products and prohormones. If your formula resembles anything on that list, expect scrutiny even if your brand is not named. Violations of the Unapproved substances policy are not suspended on first detection; Google says a warning is issued at least 7 days before any account suspension.
On audiences, Google's personalized advertising policy lists health as a sensitive interest category, and advertisers whose products fall within a sensitive category cannot use advertiser-curated audiences such as customer match. Check whether your product falls inside that category before you plan remarketing around it.
Meta's rules sit in its Advertising Standards, under Health and Wellness. Ads for dietary weight loss or weight gain products, such as supplements or pills, must target people 18 or older. Inside that limit, Meta says the ad can show use of the product, the impact of use, or a clear indication of the time it takes to see noticeable results. What Meta does not allow in this context: close-ups of a body area with pinched fat, statements of inferiority about someone's appearance, claims that results come solely from a wearable product, claims to eliminate the incurable diseases on its list, and clickbait such as exaggerated claims or promised outcomes within a set timeframe without qualifiers.
Meta's Personal Attributes policy matters as much. Ads must not assert or imply a person's physical or mental health, including medical conditions. "Do you have diabetes?" is Meta's own example of a rejected line; "New diabetes treatment available" is its example of an accepted one. Talk about the product, never about the reader's body.
Sexual wellness and men's health products have their own section. Meta does not allow ads for products that focus on sexual pleasure or enhancement. It allows sexual and reproductive health products when targeted at people 18 or older, as long as the focus is on health and not on pleasure or enhancement.
Both platforms reserve the right to re-review ads after they go live. An ad that ran for three weeks can still be rejected in week four if a reviewer or model looks at it again.
Claim language: accepted vs flagged
In the US, the FDA does not approve dietary supplements before they are sold, and the FTC regulates their advertising. The two agencies draw the line in the same place: a supplement can describe how an ingredient supports the normal structure or function of the body, but a product presented as treating or preventing a disease meets the legal definition of a drug.
The FDA calls the first kind a structure/function claim and gives examples such as "calcium builds strong bones" and "fiber maintains bowel regularity". These claims are not pre-approved by the FDA. The manufacturer must have substantiation that the claim is truthful and not misleading, must notify the FDA within 30 days of marketing a supplement with the claim, and must carry the standard disclaimer that the FDA has not evaluated the statement and that the product is not intended for disease use. Copy that disclaimer's exact wording from the FDA rather than paraphrasing it.
The FTC's Health Products Compliance Guidance is the document to read before writing any ad copy. Three points from it shape everything else. First, the FTC judges the net impression of the whole ad, including the product name, images and charts, not just the literal words. Second, every objective health claim needs competent and reliable scientific evidence, and the FTC applies that standard whether or not the claim counts as structure/function under FDA rules. Third, a disclaimer only helps if consumers notice and understand it, and it cannot contradict the claim it sits next to.
In practice, copy that tends to pass describes the ingredient, the dose, the format and the routine: what is in it, how much, how to take it, what it is designed to support. Copy that gets flagged names a condition, compares the product to a medicine, promises a specific result by a specific date, or addresses the reader's body directly. If you cannot point to the study behind a sentence, delete the sentence.
The FTC guidance says advertisers should not make claims through customer testimonials or expert endorsements that would be deceptive, or could not be substantiated, if the advertiser made them directly.
Creative that converts inside the rules
The compliant creative that works in this category sells the product as a product. Show the capsule, the powder, the label and the ingredient panel. Show how it fits into a morning routine. Show the people who buy it using it, without implying what it did to their bodies. Lead with what is genuinely different: sourcing, third-party testing you can document, dose transparency, taste, price per serving, subscription flexibility.
Before-and-after imagery is where supplement brands get into the most trouble. Meta lists before-and-after transformations as allowed only for general cosmetic products and procedures, targeted at 18+. For an ingestible product, a transformation image implies a result, and under the FTC's net impression standard that implied result is a claim that needs evidence. The safer default for supplements is no transformation imagery at all.
UGC and creator content need the same review as studio work. A creator's script is your ad copy once you run it, so brief creators on which words they cannot use and review every cut before it goes live. Rotate creative on a schedule rather than waiting for fatigue, so you are never pushing a hastily edited ad through review because the only live one stopped working. Our disapproved ads workflow covers what to do when a specific ad is rejected.
Landing pages must match the ad
Both platforms review the destination, not just the ad. Google's ad review covers the headline, description, keywords, destination, images and video. Meta's review can include the ad destination, such as a website. A compliant ad that sends people to a page full of disease claims is a non-compliant ad.
The page also counts as advertising for FTC purposes, which defines advertising to include packaging, labeling and digital content. So the rules from the claim language section apply to the product page, the reviews widget, the FAQ and any blog post you link from the ad. Audit them together.
Practical checks before launch: the product name and imagery on the page match the ad; every benefit stated on the page has substantiation on file; the FDA disclaimer appears wherever a structure/function claim does; customer reviews that make disease claims are moderated out of the widget; and nothing on the page tells a visitor what condition they have.
Never build one page for the reviewer and another for customers. Google defines that as cloaking under its Circumventing systems policy, and says violations lead to suspension upon detection, without prior warning, with no permission to advertise again. Meta treats any attempt to evade its review process as grounds for restrictions on the business portfolio, ad account, Page or user account. The page that passes review has to be the page people see.
Account and structure safeguards
In a restricted category the account is the asset. A single policy strike can stop all spend, so structure the account to keep problems contained and visible.
Keep a written claims library: every approved sentence, the evidence behind it and the date it was last checked. Copywriters and creators work from the library, and anything new goes through review before it is uploaded. Separate campaigns by product line so a disapproval on one formula does not pull down ads for another. Use the right age targeting from the start rather than relying on the platform to correct it.
Know how each platform enforces. Google suspends immediately for egregious violations, and for repeat violations of other policies it sends a warning at least 7 days before suspending. Repeated breaches follow a three-strike system: temporary holds for the first two strikes and suspension on the third. Meta says ads are reviewed mostly by automated systems, usually within 24 hours, and may be reviewed again after going live; editing targeting or creative triggers a new review.
What fails, plainly: altered spellings to dodge text detection, hiding an ingredient from the label or the page, swapping the landing page after approval, and opening new accounts to keep running ads that got an account restricted. Google names variations of disapproved ads and domains, and new accounts created after a suspension, as violations of Circumventing systems. Meta lists creating new ad accounts to repeat violations, and coordinating a network of accounts, as evading enforcement. These tactics turn a single rejected ad into the loss of every ad account connected to the business.
If an account is already in trouble, follow the recovery workflows for a suspended Google Ads account or a disabled Meta ad account. Appeal honestly, fix the cause first, and appeal once.
Meta says it may consider an advertiser's historical compliance when deciding how closely to review an ad. A clean record is worth protecting for its own sake.
Measuring supplement campaigns
Supplement economics are usually about repeat purchase, so judge campaigns on what a new customer is worth over several orders, not on the first order alone. A campaign that looks expensive on first-order ROAS can be the most profitable in the account once subscriptions renew.
Get the tracking right before you scale. Restricted categories often run with fewer audience options, which makes the conversion signal you send back to the platform even more important for optimization. Our conversion tracking guide covers the setup, and the Meta CAPI audit workflow checks that server events are arriving as expected.
Track compliance alongside performance: disapproval rate, time spent in review, and the share of spend on ads that went live without edits. A rising disapproval rate is an early warning that copy is drifting from the claims library. Finally, test whether the spend is causing sales rather than claiming them, using the methods in our guide to measuring PPC incrementality.
What this looks like in practice
iClick runs paid media for brands in restricted categories, and two of our published case studies sit squarely in this space.
Lynk Pleasure is a restricted wellness brand. After a rebuild of its Google Search account around tighter segmentation and compliance discipline, it reached 3.4x ROAS over three months in Google Ads, with 48% more conversions and a 50% lower CPA.
The Enhanced Male is a men's health brand in a category Meta keeps tightening. The work centred on a compliance-first creative pipeline and a mix of channels beyond Meta, which kept the account healthy while revenue grew 278% at a 3.78x ROAS.
Both accounts follow the approach in this guide: claims the brand can support, creative reviewed before upload, landing pages that match the ads, and no shortcuts around review. See how we run restricted-category accounts on our ecommerce PPC page.
